Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abdominal, accused, acute, addressed, affirmative, aimed, al, altogether, Appellate, appointed, appointment, apportionment, art, ASC, bearing, bifurcated, bioavailablity, Bipartisan, carcinogenicity, Carlo, chose, climate, CMS, CNS, commute, Compact, consecutive, contra, curb, Deferral, detrimental, Diarrhea, diversify, divestiture, estate, evenly, expiry, fatal, fierce, fleet, Franchise, Francisco, friction, Gillette, headquartered, hospitaland, host, House, Imputation, inclement, incremental, instrument, inter, IPR, leadership, lender, lifecycle, lifespan, Lonza, matched, Mateo, metric, moiety, Monte, MTC, multinational, Multistate, overturned, rare, realignment, redistribution, relocate, relocation, residual, Retention, retired, retirement, seasonal, shift, shifted, simplify, Simplifying, style, Supreme, synergistic, talented, thatASU, TherapeuticEquivalence, threatening, titration, top, turnover, twelve, unnecessary, unsure, vehicle, vomiting, weather, wind, workload
Removed:
Abbott, acetate, achievable, acitretin, acquiree, adalimumab, adjacent, Affymax, alemtuzumab, alter, anthrolin, ascending, assigned, aubagio, autoimmunity, avonex, Bayer, Beecham, belief, betaseron, BID, Bucknell, Chicago, cognition, cohort, collaborative, combinatorial, consultant, contact, content, Cooley, coordinated, copaxone, counsel, cure, cyclosporine, daclizumab, deferring, diagnosed, employing, enbrel, etanercept, Europe, experiencing, extavia, fingolimod, foregone, gene, genetic, gilenya, glatiramer, heading, highest, humira, immune, Impax, inflammatory, infliximab, interpret, intervention, invalidity, laquinimod, leased, lemtrada, living, merged, methotrexate, MMA, mobility, Modernization, molecular, morning, morphology, myelin, natralizumab, neurodegenerative, Neuroscience, North, occupation, originally, Osmotica, petitioned, pharmacologist, pharmacology, pipeline, plc, predisposition, preexisting, premium, progressively, protein, ready, rebif, reconstitute, red, relapse, remicade, remission, reserved, rigidity, rytary, scaling, scenario, shaking, Sixty, SmithKline, smooth, stalevo, stelara, stroke, suffering, Sun, synthetic, teriflunomide, terminable, thick, topical, tremor, typical, tysabri, ultimate, unchanged, unconsolidated, undergoing, unusually, ustekinumab, variability, vitamin, Wellcome, wrong, XL
Filing tables
Filing exhibits
Related press release
XNPT similar filings
Filing view
External links